Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1324 of 5804
-
New hope for kids with rare muscle disease: rozanolixizumab safety trial expands
Disease control ENROLLING_BY_INVITATIONThe purpose of the study is to assess the long term safety and tolerability of additional 6-week treatment cycles with rozanolixizumab in pediatric participants with generalized Myasthenia Gravis (gMG) aged ≥2 at the time of the Screening Visit of MG0006.
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New diabetes combo aims to lower blood sugar in phase 3 trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Parents as therapists: new autism trial tests Home-Based training
Symptom relief ENROLLING_BY_INVITATIONPurpose of the Research: The goal of this clinical study is to investigate if a parent training program called "Project IMPACT" (Improving Parents as Communication Teachers) can help improve the core challenges in social interaction and communication for children with Autism Spe…
Phase: NA • Sponsor: University of Electronic Science and Technology of China • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can a home gluten test help heal celiac disease?
Disease control Recruiting nowThe investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention wil…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Single dose of esketamine during surgery may ward off Post-Op depression in ovarian cancer patients
Prevention CompletedThe goal of this clinical trial is to learn if intraoperative administration of esketamine would prevent or mitigate postoperative depressive symptoms after cytoreductive surgery in ovarian cancer. The main questions it aims to answer are: * Whether a single low dose of esketami…
Phase: NA • Sponsor: Zhejiang Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New hope for advanced cancers: experimental drug ACR-2316 enters first human trial
Disease control Recruiting nowThis is a first in-human, Open-label Phase 1 study to assess the safety of ACR-2316 for the treatment of subjects with specific, histologically confirmed, locally advanced, recurrent or metastatic solid tumors.
Phase: PHASE1 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New diabetes drug shows promise in Mid-Stage trial
Disease control CompletedThis is a Phase IIb, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes mellitus, compared to placebo and active comparator.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Vacuum therapy may stop deadly leaks after esophageal cancer surgery
Disease control OngoingA prospective, multi-centre, exploratory and observational one-arm study to evaluate preventive Endoluminal Vacuum Therapy(pEVT) to prevent anastomotic leakage after esophagectomy due to esophageal cancer. The main objective is to evaluate the potential protective effect of proph…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New injectable drug shows promise for tough lung cancer
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New allergy vaccine could end spring sniffles
Symptom relief OngoingThis is first-in-human phase 1/2 clinical trial to evaluate the safety, systemic and local reactogenicity of GNR-127 at the first stage in sequential cohorts of patients with allergic rhinitis with sensitization to the birch pollen, and then to determine and evaluate an effective…
Phase: PHASE1, PHASE2 • Sponsor: AO GENERIUM • Aim: Symptom relief
Last updated Jun 26, 2026 13:40 UTC
-
Artificial liver device tested in humans for first time
Disease control CompletedThe clinical trial will assess the safety of miroliverELAP for the treatment of acute liver failure, severe acute alcohol-associated hepatitis, or acute on chronic liver failure. miroliverELAP is an external liver assist combination product consisting of a single-use MIRO-001 bio…
Phase: PHASE1 • Sponsor: Miromatrix Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Emergency room study aims to boost opioid treatment success
Disease control Recruiting nowThe ADAPT-ED study is a two-stage, sequential multiple assignment randomized trial (SMART) to inform the development of an adaptive intervention that is optimally effective in increasing long-term buprenorphine use for adults presenting to the ED with probable opioid use disorder…
Phase: NA • Sponsor: RAND • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a common antifungal improve Crohn's therapy?
Disease control Recruiting nowThe goal of this clinical trial is to learn about the effects of fluconazole in patients who plan to start or are currently undergoing standard of care treatment and plan to dose-escalate an IL-23 therapy for their Crohn's disease. The main question it aims to assess is whether …
Phase: PHASE3 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a disc injection replace surgery for back pain?
Disease control OngoingVIA Disc NP is an off-the-shelf minimally processed human nucleus pulposus tissue allograft intended to supplement degenerated intervertebral discs. The study is a randomized, double-blind, sham-controlled, multi-center study in participants with symptomatic lumbar intervertebra…
Phase: PHASE2 • Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
First human test of novel heart failure drug begins
Disease control CompletedThe study is testing a new medicine to potentially treat people with heart failure. The main purpose of the study is to see if the new study medicine is safe and how it works in the body. It is the first time NNC0537-1482 (the new study medicine) is tested in humans and will be t…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Potassium binder may unlock lifesaving heart drugs for seniors
Disease control Recruiting nowHeart failure (HF) and Chronic Kidney Disease (CKD) patients are frequently not administered renin-angiotensin aldosterone system inhibitor (RAASi) therapies at recommended doses due to hyperkalaemia, despite proven mortality and morbidity benefits. Sodium zirconium cyclosilicate…
Phase: PHASE3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
MS patients may benefit from switching Immune-Suppressing drugs
Disease control OngoingTo investigate the impact on IgG and IgM concentration, infection risk and effectiveness of switching from anti-CD20 to cladribine compared to continued anti-CD20 treatment over 2 years in relapsing MS patients.
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obtained by Coculture of M2-macrophages and fat-derived Mesenchymal Stromal Cells (PRS CK STORM) in the modulation of the cy…
Phase: PHASE1, PHASE2 • Sponsor: PEACHES BIOTECH • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Balloon pump may boost heart recovery in shock patients on ECMO
Disease control Recruiting nowThe goal of this clinical trial is to compare the use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) with and without left ventricular (LV) unloading in patients being treated for cardiogenic shock (CS). The main aims of the study are: 1. To determine the physiol…
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New app aims to ease mental struggles after ICU stays
Symptom relief OngoingCritically ill survivors develop mental health, cognition, and mobility sequelae known as Post-Intensive Care Syndrome (PICS). Clinically significant symptoms of post-traumatic stress, depression, anxiety, and cognitive impairment are frequently observed at short- and long-term a…
Phase: NA • Sponsor: Corporacion Parc Tauli • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC